Skip to content

Effect of Nutritional Supplements on Clinical Outcomes in Patients With Prediabetes and Obesity

Effect of Nutritional Supplements (Ivital Control) on Clinical Outcomes in Patients With Prediabetes and Obesity:a Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05273840
Enrollment
100
Registered
2022-03-10
Start date
2021-06-11
Completion date
2022-11-30
Last updated
2022-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, PreDiabetes

Keywords

PreDiabetes, Obesity, Glycosylated hemoglobin, weight

Brief summary

This study aims to improve blood glucose and weight in patients with prediabetes and obesity through health education, nutritional supplement interventions, clinical evaluation, and close clinical follow-up.100 patients with prediabetes with obesity were randomly divided into 2 groups: life intervention group, nutritional supplement intervention group. All enrolled participants were recommended for routine diabetes lifestyle education according to the Expert Consensus on Prediabetes Intervention in Adults in China. The duration of the intervention was 3 months. The investigators aimed to compare the differences in weight, glycosylated hemoglobin, lipids and other indicators of the two groups of included populations before and after the intervention. In addition, the investigators are to explore the effects of nutritional supplement interventions on glycolipid metabolism and body weight in prediabetes with obesity.

Interventions

DIETARY_SUPPLEMENTIvital Control

Patients in the intervention group will take 2 sachets of nutritional supplements(Ivital Control) once a day in lieu of one meal, besides receiving lifestyle interventions.

BEHAVIORALlifestyle intervention

Patients will receive lifestyle interventions.

Sponsors

Ningbo No. 1 Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

1. life intervention group 2. nutritional supplement intervention group

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* According to the American Diabetes Society (ADA) 2010 standard: meet one of the following (1) fasting blood glucose at 100 mg/dl to 125 mg/dl; (2) sugar load 2h blood glucose at 140 mg/dl to 199 mg/dl; (3) glycosylated hemoglobin in 5.7% to 6.4% * Body mass index (BMI) ≥ 25 and ≤ 35kg/m2 * Have lived locally for at least half a year and have a fixed residence * No other clinical trials were participated in in the 3 months prior to the trial * Mental health, being able to take care of oneself in life

Exclusion criteria

* People with confirmed diabetes * Weight change of more than 10% over the past 3 months * Pregnant or lactating women, men and women planning to become pregnant within two years, or unwilling and unable to use contraception during the study period (women only) * People who are allergic to the ingredients of nutritional supplements * Those who have lost weight by any medication (including appetite suppressants such as fluprophenylpropanine, progesterone, laxatives, etc., and diet pills with various Traditional Chinese medicine ingredients) or surgery in the past 3 months * Patients who have received medical treatment for the following diseases in the past 3 months: diabetes, cholecystitis, peptic ulcer, inflammatory bowel disease, acute urinary tract infection, hyperthyroidism, etc., or patients with chronic gastrointestinal diseases with symptoms of nausea, vomiting and diarrhea in the past month * Suffer from severe organic diseases such as cancer, coronary heart disease, myocardial infarction and stroke * Presence of pituitary-adrenal axis dysfunction; secondary obesity due to other diseases (e.g., Cushing syndrome, hypothyroidism, etc.)

Design outcomes

Primary

MeasureTime frameDescription
the proportions of participants regressing back to normal glucose level3 monthsThe normal glucose level was defined as FPG \< 6.1 mmol/L and 2hPG \< 7.8 mmol/L during the OGTT.

Secondary

MeasureTime frameDescription
change in HbA1c3 monthschange in HbA1c
body weight3 monthschanges in body weight

Other

MeasureTime frameDescription
changes in visceral fat area3 monthsbody composition
changes in body fat percentage3 monthsbody composition
changes in waist circumference3 monthsanthropometric parameters
blood lipids3 monthschanges in LDL-cholesterol, HDL-cholesterol
changes in triglyceride level (blood lipids)3 monthschanges in triglyceride
changes in lean mass3 monthsbody composition
changes in hip circumference3 monthsanthropometric parameters
changes in neck circumference3 monthsanthropometric parameters

Countries

China

Contacts

Primary ContactLi Li, Bachelor of Medicine degree
lilyningbo@163.com8613757426626

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026